The amelioration of renal damage in Skp2-deficient mice canceled by p27Kip1 deficiency in Skp2-/- p27-/- mice

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Suzuki, Sayuri ^a   Fukasawa, Hirotaka ^a   Misaki, Taro ^a,e   Togawa, Akashi ^a   Ohashi, Naro ^a   Kitagawa, Kyoko ^a   Kotake, Yojiro ^a   Liu, Ning ^a   Niida, Hiroyuki ^a   Nakayama, Keiko ^b   Nakayama, Keiichi I ^c   Yamamoto, Tatsuo ^a,d   Kitagawa, Masatoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d Numazu City Hospital   (Japan)

^e SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; MYC PROTEIN; PROTEIN MYB; PROTEIN P130; PROTEIN P21; PROTEIN P57; S PHASE KINASE ASSOCIATED PROTEIN 2; S PHASE KINASE ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; KIDNEY TUBULE DISORDER; MALE; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; URETER OBSTRUCTION; ANIMAL; FIBROSIS; GENE INACTIVATION; GENETICS; KIDNEY DISEASE; KIDNEY TUBULE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FIBROSIS; GENE KNOCKOUT TECHNIQUES; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MICE; S-PHASE KINASE-ASSOCIATED PROTEINS; URETERAL OBSTRUCTION;

EID: 84860430411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036249     Document Type: Article

References (37)

1. Morgan DO, (1995) Principles of CDK regulation. Nature 374: 131-134.
2. Sherr CJ, Roberts JM, (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Gene & Dev 9: 1149-1163.
3. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, et al. (1994) Interlukin-2-mediated elimination of the p27kip1 cyclin-dependent kinases inhibitor prevented by rapamycin. Nature 372: 570-573.
4. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, et al. (1994) Cloning of p27kip1, a cyclin-dependent kinases inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
5. Coats S, Flanagan WM, Nourse J, Roberts JM, (1996) Requirement of p27kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877-880.
6. Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, et al. (1997) Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27kip1. Kidney Int 51: 1088-1099.
7. Kamb A, (1995) Cell-cycle refulators and cancer. Trends Genet 11: 136-140.
8. Weinberg RA, (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
9. Weissman AM, (1997) Regulating protein degradation by ubiquitination. Immunol. Today 18: 189-198.
10. Hershko A, Ciechanover A, (1998) The ubiqutin system. Annu Rev Biochem 67: 425-479.
11. Carrano AC, Eytan E, Hershko A, Pagano M, (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193-199.
12. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H, et al. (1999) p27(Kip1) ubiqutination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9: 661-664.
13. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, et al. (2000) Targeted disruption of Skp2 results in accumulation of cyclin E and p27kip1, polyploidy and centrosome overdupication. EMBO J 19 (9): 2069-2081.
14. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, et al. (2001) The cell-cycle regulatory protein Cks1 is required for SCF-Skp2-mediated ubiqutinylation of p27. Nat Cell Biol 3: 321-324.
15. Frescas D, Pagano M, (2008) Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat Rev Cancer 8: 438-449.
16. Walton G, Buttyan R, Garcia ME, Olsson CA, Hensle TW, et al. (1992) Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148: 510-514.
17. Saulo K, Jeremiah M, (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875.
18. Gobe GC, Axelsen RA, (1987) Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56: 273-281.
19. Morrissey JJ, Ishidoya S, McCrachen R, Klahr S, (1996) Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction. Kidney Int Suppl 57: S84-S92.
20. Gerth JH, Kriegsmann J, Trinh TT, Stahl RA, Wendt T, et al. (2002) Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensis II. Kidney Int 61: 68-79.
21. Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, et al. (2002) Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 160 (3): 1181-1191.
22. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ, (1998) The cyclin-dependent kinases inhibitor p27kip1 safeguards against inflammatory injury. Nature Med 4: 575-58.
23. Hughes J, Brown P, Shankland SJ, (1999) Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol 277: 948-956.
24. Suzuki S, Fukasawa H, Kitagawa K, Uchida C, Hattori T, et al. (2007) Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice. Am J Pathol 171 (2): 473-483.
25. Suzuki S, Fukasawa H, Misaki T, Togawa A, Ohashi N, et al. (2011) Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy. Genes Cells 16 (11): 1110-1120.
26. Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, et al. (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278 (28): 25752-25757.
27. Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, et al. (2003) Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci 100 (18): 10231-10216.
28. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, et al. (2003) The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11 (5): 1189-1200.
29. Tedesco D, Lukas J, Reed SI, (2002) The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 16 (22): 2946-2957.
30. Hiramatsu Y, Kitagawa K, Suzuki T, Uchida C, Hattori T, et al. (2006) Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res 66 (17): 8477-8483.
31. Starostina NG, Kipreos ET, (2012) Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol 22 (1): 33-41.
32. Sicari BM, Troxell R, Salim F, Tanwir M, Takane KK, et al. (2012) c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein. Endocrinology 153 (2): 861-872.
33. Carew RM, Wang B, Kantharidis P, (2011) The rople of EMT in renal fibrosis: Cell Tissue Res 347 (1): 103-116.
34. Hay ED, Zuk A, (1995) Transformations between epithelium and mesenchyme: noemal, pathological, and experimentally induced. Am J Kidney Dis 26: 678-690.
35. Kalluri R, Neilson EG, (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784.
36. Zeisberg M, Kalluri R, (2004) The role epithelial-to mesenchymal transition in renal fibrosis. J Mol Med 82 (3): 175-181.
37. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, et al. (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors: Cell 85 (5): 707-720.